Essex Woodlands Management, Inc. Axogen, Inc. Transaction History

Essex Woodlands Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $2.15 Million - $3.17 Million	-296,416 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $8.63 Million - $15.7 Million	-980,229 Reduced 76.78%	296,416 $2.78 Million
Q2 2021 Aug 13, 2021	SELL	$17.8 - $23.5 $8.6 Million - $11.4 Million	-483,054 Reduced 27.45%	1,276,645 $27.6 Million
Q1 2021 May 14, 2021	SELL	$17.18 - $22.6 $3.82 Million - $5.02 Million	-222,189 Reduced 11.21%	1,759,699 $35.7 Million
Q3 2020 Nov 13, 2020	SELL	$10.62 - $13.12 $4.76 Million - $5.88 Million	-448,111 Reduced 18.44%	1,981,888 $23 Million
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $5.73 Million - $7.89 Million	-309,752 Reduced 11.31%	2,429,999 $48.1 Million
Q4 2018 Feb 14, 2019	SELL	$17.09 - $38.25 $16.6 Million - $37.2 Million	-971,360 Reduced 26.17%	2,739,751 $56 Million
Q4 2017 Feb 13, 2018	SELL	$18.5 - $28.6 $21.3 Million - $32.9 Million	-1,150,000 Reduced 23.66%	3,711,111 $105 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $71.2 Million - $94.1 Million	4,861,111	4,861,111 $94.1 Million

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $693M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Essex Woodlands Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Essex Woodlands Management, Inc. with notifications on news.